Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJun 5, 2024Pain WizardOut of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.ARG Laboratories, Inc. · D-0524-2024Class IIOngoingJun 5, 2024ALOE GATOROut of Specification for active ingredientARG Laboratories, Inc. · D-0523-2024Class IIOngoingJun 5, 2024Bull Frog SPF 50 Amphibious Lotion SPF 50 Amphibious Lotion with Water Armor TechOut of Specification for active ingredientARG Laboratories, Inc. · D-0522-2024Class IIOngoingJun 5, 2024NATURAL PAIN RELIEVING CREAMOut of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.ARG Laboratories, Inc. · D-0521-2024Class IIOngoingJun 5, 2024Pain WizardOut of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.ARG Laboratories, Inc. · D-0520-2024Class IIOngoingJun 5, 2024Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular...Lack of Assurance of SterilityImprimis NJOF, LLC · D-0519-2024Class IITerminatedJun 5, 2024Cefdinir for Oral Suspension USPDefective container: lack of seal integrity.Lupin Pharmaceuticals Inc. · D-0518-2024Class IIOngoingJun 5, 2024Metoprolol Tartrate Tablets USPPresence of Foreign Substance: metal in tabletRubicon Research Private Limited · D-0517-2024Class IIOngoingJun 5, 2024Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular InjectionLack of Assurance of SterilityImprimis NJOF, LLC · D-0516-2024Class IIOngoingJun 5, 2024Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular InjectionLack of Assurance of SterilityImprimis NJOF, LLC · D-0515-2024Class IIOngoingJun 5, 2024Dexamethasone-Moxifloxacin- KetorolacLack of Assurance of SterilityImprimis NJOF, LLC · D-0514-2024Class IIOngoingJun 5, 2024Dexamethasone-MoxifloxacinLack of Assurance of SterilityImprimis NJOF, LLC · D-0513-2024Class IIOngoingJun 5, 2024Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular...Lack of Assurance of SterilityImprimis NJOF, LLC · D-0512-2024Class IOngoingJun 5, 2024Tirzepatide 10 mg/0.5 mL Sterile SolutionLabeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionateRevive Rx LLC dba Revive Rx Pharmacy · D-0511-2024Class IIOngoingJun 5, 2024Zoledronic Acid Injection 5mg/100mL Sterile SolutionLack of Assurance of Sterility: Leaking vialsDr. Reddy's Laboratories, Inc. · D-0510-2024Class IITerminatedJun 5, 2024Cathflo activaseLack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.Genentech, Inc. · D-0509-2024Class ICompletedMay 29, 2024Phenylephrine in 0.9% Sodium Chloride Injection Preservative FreeLabeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.Hikma Injectables USA Inc · D-0508-2024Class IITerminatedMay 29, 2024Vasopressin InjectionSubpotent product in addition to having out-of-specification results for impurities.American Regent, Inc. · D-0507-2024Class IIOngoingMay 29, 2024Haloperidol decanoate Injection 50mg/mLPresence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).Somerset Therapeutics LLC · D-0506-2024Class IIOngoingMay 29, 2024Duloxetine Delayed-Release Cap USP 30mgCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitPreferred Pharmaceuticals, Inc. · D-0505-2024Class IIIOngoingMay 29, 2024Sirolimus Tablets 1mg TabletsFailed Impurities/Degradation SpecificationsDr. Reddy's Laboratories, Inc. · D-0504-2024Class IITerminatedMay 29, 2024niCARdipine Hydrochloride InjectionLack of Assurance of Sterility.American Regent, Inc. · D-0503-2024Class IIIOngoingMay 29, 2024XelprosFailed Release Testing: Out of specification for particulate matter test.Sun Pharmaceutical Industries Inc · D-0502-2024Class IIOngoingMay 22, 2024Meijer Magnesium Citrate Saline Laxative Oral Solution Dye FreeMicrobial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteriaPharma Nobis LLC · D-0501-2024Class IIOngoingMay 22, 2024CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Cherry FlavorMicrobial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteriaPharma Nobis LLC · D-0500-2024Class IIOngoingMay 22, 2024MethylPREDNISolone Acetate Injectable SuspensionPresence of Particulate Matter: Potential for black particulates in the drug product.Sagent Pharmaceuticals · D-0499-2024Class IIOngoingMay 22, 2024Losartan Potassium and Hydrochlorothiazide TabletsPresence of foreign substance: plastic-like substance.Macleods Pharma USA, Inc · D-0498-2024Class IITerminatedMay 22, 2024Cefdinir for Oral Suspension USP 125 mg/5 mLPresence of foreign substance: Product complaint of foreign material in reconstituted bottle.Lupin Pharmaceuticals Inc. · D-0497-2024Class IITerminatedMay 22, 2024Cefdinir for Oral Suspension USP 250 mg/5 mLPresence of foreign substance: Product complaint of foreign material in reconstituted bottle.Lupin Pharmaceuticals Inc. · D-0496-2024Class IICompletedMay 22, 2024Gordofilm Wart RemovercGMP DeviationsDercher Enterprises, Inc., DBA Gordon Laboratories · D-0495-2024Class ITerminatedMay 22, 2024Schwinnng Herbal Dietary Supplement CapsulesMarketed Without An Approved NDA/ANDAStop Clopez Corp · D-0494-2024Class IIOngoingMay 15, 2024Amphotericin B Liposome for InjectionOut of specification for assaySun Pharmaceutical Industries Inc · D-0493-2024Class IIOngoingMay 15, 2024Clorazepate Dipotassium TabletsDiscoloration: Dotted and yellow spots on tabletsAurobindo Pharma USA Inc. · D-0492-2024Class IIOngoingMay 15, 2024Clorazepate Dipotassium TabletsDiscoloration: Dotted and yellow spots on tabletsAurobindo Pharma USA Inc. · D-0491-2024Class IIITerminatedMay 15, 2024Sodium Sulfacetamide 10% - Sulfur 5% CleanserSubpotent drugAcella Pharmaceuticals, LLC · D-0490-2024Class IITerminatedMay 15, 2024TraMADol HCl 50 mg TabletPresence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadolRemedyRepack Inc. · D-0489-2024Class IITerminatedMay 15, 2024Timolol Maleate Ophthalmic SolutionDefective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.FDC Limited · D-0488-2024Class IIOngoingMay 15, 2024traMADol Hydrochloride TabletsPresence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadolRubicon Research Private Limited · D-0487-2024Class IOngoingMay 15, 2024Sapropterin Dihydrochloride Powder for Oral Solution 100mgSub-potent Drug; powder discoloration associated with decreased potencyDr. Reddy's Laboratories, Inc. · D-0486-2024Class IOngoingMay 15, 2024JavygtorSub-potent Drug; powder discoloration associated with decreased potencyDr. Reddy's Laboratories, Inc. · D-0485-2024

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.